Musculoskeletal Drugs
65 FDA-approved drugs
TheraRadar tracks 65 FDA-approved musculoskeletal drugs from 43 companies across 7 drug classes, led by Novartis, with 314 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Musculoskeletal.
Musculoskeletal Approvals by Year
'15
'16
2
'17
'18
2
'19
'20
'21
'22
1
'23
'24
3
'25
'26
Recent Musculoskeletal Drug Approvals
OSVYRTI
denosumab-desu
postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporot...
2025-10-29
ACCORD BIOPHARMA INC.
JUBEREQ
denosumab-desu
postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporot...
2025-10-29
ACCORD BIOPHARMA INC.
ATMEKSI
METHOCARBAMOL
ATMEKSI (methocarbamol) oral suspension is a muscle relaxant indicated as: an adjunct to rest, physi...
2025-07-30
ROSEMONT PHARMS
TERIPARATIDE
TERIPARATIDE
Teriparatide Injection is indicated: For the treatment of postmenopausal women with osteoporosis at ...
2023-11-16
Apotex
BONSITY
TERIPARATIDE
BONSITY is indicated: For the treatment of postmenopausal women with osteoporosis at high risk for f...
2019-10-04
ALVOGEN
EVENITY
ROMOSOZUMAB-AQQG
osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic...
2019-04-09
Amgen
ZILRETTA
TRIAMCINOLONE ACETONIDE
ZILRETTA (triamcinolone acetonide extended-release injectable suspension) is indicated as an intra-a...
2017-10-06
PACIRA PHARMS INC
TYMLOS
ABALOPARATIDE
postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporot...
2017-04-28
RADIUS
IBANDRONATE SODIUM
IBANDRONATE SODIUM
the treatment and prevention of postmenopausal osteoporosis...
2012-03-19
ORBION PHARMS
BINOSTO
ALENDRONATE SODIUM
osteoporosis in postmenopausal women...
2012-03-12
RADIUS
ATELVIA
RISEDRONATE SODIUM
postmenopausal osteoporosis ( 1...
2010-10-08
APIL
METAXALONE
METAXALONE
INDICATIONS AND USAGE Metaxalone is indicated as an adjunct to rest, physical therapy, and other mea...
2010-03-31
AMNEAL PHARMS
XIAFLEX
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
adult patients with Dupuytren’s contracture with a palpable cord...
2010-02-02
AUXILIUM PHARMS
CALCITONIN-SALMON
CALCITONIN SALMON
symptomatic Paget's disease of bone in patients with moderate to severe disease characterized by pol...
2008-11-17
Fresenius Kabi
ALENDRONATE SODIUM
ALENDRONATE SODIUM
osteoporosis in postmenopausal women...
2008-02-06
WATSON LABS INC
RISEDRONATE SODIUM
RISEDRONATE SODIUM
postmenopausal osteoporosis (1...
2007-10-05
Teva
REVONTO
DANTROLENE SODIUM
INDICATIONS AND USAGE Revonto (dantrolene sodium for injection) is indicated, along with appropriate...
2007-07-24
USWM
RECLAST
ZOLEDRONIC ACID
osteoporosis in postmenopausal women...
2007-04-16
Novartis
AMRIX
CYCLOBENZAPRINE HYDROCHLORIDE
AMRIX ® (cyclobenzaprine hydrochloride extended-release capsules) is indicated as an adjunct to rest...
2007-02-01
Teva
FORTICAL
CALCITONIN SALMON RECOMBINANT
2005-08-12
UPSHER SMITH LABS
Showing the 20 most recent of 65 musculoskeletal drugs. View all 65 →
Top Musculoskeletal Companies
Musculoskeletal Active Trials by Indication
314 active trials — the forward pipeline, not just approvals.
All competitive landscapes →Musculoskeletal Drug Classes
Muscle Relaxant 4
RANK Ligand Inhibitor 2
Parathyroid Hormone Analog 2
Parathyroid Hormone-Related Peptide Analog 1
Calcitonin 1
Vitamin D 1
Nonsteroidal Anti-inflammatory Drug 1
Musculoskeletal at a Glance
- Total Drugs
- 65
- Companies
- 43
- Drug Classes
- 7
- Active Trials
- 314
- Latest Approval
- 2025-10-29